{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T03:11:32Z","timestamp":1794971492879,"version":"4.9.1"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000060","name":"U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["U01-AI141995"],"award-info":[{"award-number":["U01-AI141995"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["U19-AI142742"],"award-info":[{"award-number":["U19-AI142742"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["U01-AI187062"],"award-info":[{"award-number":["U01-AI187062"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["U01-AI150753"],"award-info":[{"award-number":["U01-AI150753"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-025-58460-8","type":"journal-article","created":{"date-parts":[[2025,4,2]],"date-time":"2025-04-02T05:31:27Z","timestamp":1743571887000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Th1 polarization in Bordetella pertussis vaccine responses is maintained through a positive feedback loop"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9676-9249","authenticated-orcid":false,"given":"Lisa","family":"Willemsen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiyeun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pramod","family":"Shinde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ferran","family":"Soldevila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minori","family":"Aoki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shelby","family":"Orfield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mari","family":"Kojima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9785-5272","authenticated-orcid":false,"given":"Ricardo","family":"da Silva Antunes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7013-2250","authenticated-orcid":false,"given":"Alessandro","family":"Sette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8457-6693","authenticated-orcid":false,"given":"Bjoern","family":"Peters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,1]]},"reference":[{"key":"58460_CR1","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.3201\/eid3005.231278","volume":"30","author":"BA Noble","year":"2024","unstructured":"Noble, B. A., Jiudice, S. S., Jones, J. D. & Timbrook, T. T. Reemergence of Bordetella parapertussis, United States, 2019\u20132023. Emerg. Infect. Dis. 30, 1058\u20131060 (2024).","journal-title":"Emerg. Infect. Dis."},{"key":"58460_CR2","doi-asserted-by":"publisher","first-page":"q736","DOI":"10.1136\/bmj.q736","volume":"385","author":"E Smout","year":"2024","unstructured":"Smout, E., Mellon, D. & Rae, M. Whooping cough rises sharply in UK and Europe. BMJ 385, q736 (2024).","journal-title":"BMJ"},{"key":"58460_CR3","doi-asserted-by":"publisher","first-page":"S310","DOI":"10.1093\/infdis\/jiaa469","volume":"224","author":"MD Decker","year":"2021","unstructured":"Decker, M. D. & Edwards, K. M. Pertussis (whooping cough). J. Infect. Dis. 224, S310\u2013S320 (2021).","journal-title":"J. Infect. Dis."},{"key":"58460_CR4","unstructured":"(CDC) CfDCaP. Whooping cough (pertussis) vaccination 2022 https:\/\/www.cdc.gov\/vaccines\/vpd\/pertussis\/index.html (2022)."},{"key":"58460_CR5","doi-asserted-by":"publisher","first-page":"e1004138","DOI":"10.1371\/journal.pcbi.1004138","volume":"11","author":"M Gambhir","year":"2015","unstructured":"Gambhir, M. et al. A change in vaccine efficacy and duration of protection explains recent rises in pertussis incidence in the United States. PLoS Comput. Biol. 11, e1004138 (2015).","journal-title":"PLoS Comput. Biol."},{"key":"58460_CR6","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1093\/cid\/cit046","volume":"56","author":"MA Witt","year":"2013","unstructured":"Witt, M. A., Arias, L., Katz, P. H., Truong, E. T. & Witt, D. J. Reduced risk of pertussis among persons ever vaccinated with whole cell pertussis vaccine compared to recipients of acellular pertussis vaccines in a large US cohort. Clin. Infect. Dis. 56, 1248\u20131254 (2013).","journal-title":"Clin. Infect. Dis."},{"key":"58460_CR7","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1080\/22221751.2018.1564630","volume":"8","author":"MM Wilk","year":"2019","unstructured":"Wilk, M. M. et al. Immunization with whole cell but not acellular pertussis vaccines primes CD4 T(RM) cells that sustain protective immunity against nasal colonization with Bordetella pertussis. Emerg. Microbes Infect. 8, 169\u2013185 (2019).","journal-title":"Emerg. Microbes Infect."},{"key":"58460_CR8","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1073\/pnas.1314688110","volume":"111","author":"JM Warfel","year":"2014","unstructured":"Warfel, J. M., Zimmerman, L. I. & Merkel, T. J. Acellular pertussis vaccines protect against disease but fail to prevent infection and transmission in a nonhuman primate model. Proc. Natl Acad. Sci. USA 111, 787\u2013792 (2014).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"58460_CR9","first-page":"300","volume":"326","author":"BM Kuehn","year":"2021","unstructured":"Kuehn, B. M. Resurgence of pertussis linked with switch to acellular vaccine. JAMA 326, 300 (2021).","journal-title":"JAMA"},{"key":"58460_CR10","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1056\/NEJMoa1200850","volume":"367","author":"NP Klein","year":"2012","unstructured":"Klein, N. P., Bartlett, J., Rowhani-Rahbar, A., Fireman, B. & Baxter, R. Waning protection after fifth dose of acellular pertussis vaccine in children. N. Engl. J. Med. 367, 1012\u20131019 (2012).","journal-title":"N. Engl. J. Med."},{"key":"58460_CR11","doi-asserted-by":"publisher","first-page":"e20153326","DOI":"10.1542\/peds.2015-3326","volume":"137","author":"NP Klein","year":"2016","unstructured":"Klein, N. P., Bartlett, J., Fireman, B. & Baxter, R. Waning Tdap effectiveness in adolescents. Pediatrics 137, e20153326 (2016).","journal-title":"Pediatrics"},{"key":"58460_CR12","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.3389\/fimmu.2019.01344","volume":"10","author":"S Esposito","year":"2019","unstructured":"Esposito, S. et al. Pertussis prevention: reasons for resurgence, and differences in the current acellular pertussis vaccines. Front. Immunol. 10, 1344 (2019).","journal-title":"Front. Immunol."},{"key":"58460_CR13","doi-asserted-by":"crossref","unstructured":"Burdin, N., Handy, L. K., Plotkin, S. A. What is wrong with pertussis vaccine immunity? The problem of waning effectiveness of pertussis vaccines. Cold Spring Harb. Perspect. Biol. 9, a029454 (2017).","DOI":"10.1101\/cshperspect.a029454"},{"key":"58460_CR14","doi-asserted-by":"publisher","first-page":"ftv051","DOI":"10.1093\/femspd\/ftv051","volume":"73","author":"G Fedele","year":"2015","unstructured":"Fedele, G., Cassone, A. & Ausiello, C. M. T-cell immune responses to Bordetella pertussis infection and vaccination. Pathog. Dis. 73, ftv051 (2015).","journal-title":"Pathog. Dis."},{"key":"58460_CR15","doi-asserted-by":"publisher","first-page":"3853","DOI":"10.1172\/JCI121309","volume":"128","author":"R da Silva Antunes","year":"2018","unstructured":"da Silva Antunes, R. et al. Th1\/Th17 polarization persists following whole-cell pertussis vaccination despite repeated acellular boosters. J. Clin. Invest. 128, 3853\u20133865 (2018).","journal-title":"J. Clin. Invest."},{"key":"58460_CR16","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.cellimm.2016.05.002","volume":"304-305","author":"T Bancroft","year":"2016","unstructured":"Bancroft, T. et al. Th1 versus Th2 T cell polarization by whole-cell and acellular childhood pertussis vaccines persists upon re-immunization in adolescence and adulthood. Cell Immunol. 304-305, 35\u201343 (2016).","journal-title":"Cell Immunol."},{"key":"58460_CR17","doi-asserted-by":"publisher","first-page":"51","DOI":"10.3389\/fimmu.2018.00051","volume":"9","author":"S van der Lee","year":"2018","unstructured":"van der Lee, S., Hendrikx, L. H., Sanders, E. A. M., Berbers, G. A. M. & Buisman, A. M. Whole-cell or acellular pertussis primary immunizations in infancy determines adolescent cellular immune profiles. Front. Immunol. 9, 51 (2018).","journal-title":"Front. Immunol."},{"key":"58460_CR18","doi-asserted-by":"publisher","first-page":"8202067","DOI":"10.1155\/2020\/8202067","volume":"2020","author":"R da Silva Antunes","year":"2020","unstructured":"da Silva Antunes, R. et al. Development and validation of a Bordetella pertussis whole-genome screening strategy. J. Immunol. Res. 2020, 8202067 (2020).","journal-title":"J. Immunol. Res."},{"key":"58460_CR19","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1016\/j.chom.2023.06.015","volume":"31","author":"R da Silva Antunes","year":"2023","unstructured":"da Silva Antunes, R. et al. T cell reactivity to Bordetella pertussis is highly diverse regardless of childhood vaccination. Cell Host Microbe 31, 1404\u201316.e4 (2023).","journal-title":"Cell Host Microbe"},{"key":"58460_CR20","doi-asserted-by":"publisher","first-page":"1879","DOI":"10.1128\/CVI.00277-12","volume":"19","author":"RM Schure","year":"2012","unstructured":"Schure, R. M. et al. T-cell responses before and after the fifth consecutive acellular pertussis vaccination in 4-year-old Dutch children. Clin. Vaccin. Immunol. 19, 1879\u20131886 (2012).","journal-title":"Clin. Vaccin. Immunol."},{"key":"58460_CR21","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1126\/science.1221064","volume":"337","author":"B Pulendran","year":"2012","unstructured":"Pulendran, B. & Artis, D. New paradigms in type 2 immunity. Science 337, 431\u2013435 (2012).","journal-title":"Science"},{"key":"58460_CR22","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1016\/S0960-9822(95)00170-9","volume":"5","author":"SL Swain","year":"1995","unstructured":"Swain, S. L. T-cell subsets: who does the polarizing? Curr. Biol. 5, 849\u2013851 (1995).","journal-title":"Curr. Biol."},{"key":"58460_CR23","doi-asserted-by":"publisher","first-page":"e1003264","DOI":"10.1371\/journal.ppat.1003264","volume":"9","author":"PJ Ross","year":"2013","unstructured":"Ross, P. J. et al. Relative contribution of Th1 and Th17 cells in adaptive immunity to Bordetella pertussis: towards the rational design of an improved acellular pertussis vaccine. PLoS Pathog. 9, e1003264 (2013).","journal-title":"PLoS Pathog."},{"key":"58460_CR24","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1086\/593682","volume":"175","author":"M Ryan","year":"1997","unstructured":"Ryan, M. et al. Bordetella pertussis respiratory infection in children is associated with preferential activation of type 1 T helper cells. J. Infect. Dis. 175, 1246\u20131250 (1997).","journal-title":"J. Infect. Dis."},{"key":"58460_CR25","doi-asserted-by":"crossref","unstructured":"Manetti, R. et al. Natural killer cell stimulatory factor (interleukin 12 [IL-12]) induces T helper type 1 (Th1)-specific immune responses and inhibits the development of IL-4-producing Th cells. J. Exp. Med. 177, 1199\u20131204 (1993).","DOI":"10.1084\/jem.177.4.1199"},{"key":"58460_CR26","doi-asserted-by":"publisher","first-page":"10188","DOI":"10.1073\/pnas.90.21.10188","volume":"90","author":"RA Seder","year":"1993","unstructured":"Seder, R. A., Gazzinelli, R., Sher, A. & Paul, W. E. Interleukin 12 acts directly on CD4\u2009+\u2009T cells to enhance priming for interferon gamma production and diminishes interleukin 4 inhibition of such priming. Proc. Natl Acad. Sci. USA 90, 10188\u201310192 (1993).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"58460_CR27","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1126\/science.8097338","volume":"260","author":"CS Hsieh","year":"1993","unstructured":"Hsieh, C. S. et al. Development of TH1 CD4\u2009+\u2009T cells through IL-12 produced by Listeria-induced macrophages. Science 260, 547\u2013549 (1993).","journal-title":"Science"},{"key":"58460_CR28","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.4049\/jimmunol.151.4.1938","volume":"151","author":"CY Wu","year":"1993","unstructured":"Wu, C. Y., Demeure, C., Kiniwa, M., Gately, M. & Delespesse, G. IL-12 induces the production of IFN-gamma by neonatal human CD4 T cells. J. Immunol. 151, 1938\u20131949 (1993).","journal-title":"J. Immunol."},{"key":"58460_CR29","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/S0952-7915(98)80163-5","volume":"10","author":"H Okamura","year":"1998","unstructured":"Okamura, H., Kashiwamura, S., Tsutsui, H., Yoshimoto, T. & Nakanishi, K. Regulation of interferon-gamma production by IL-12 and IL-18. Curr. Opin. Immunol. 10, 259\u2013264 (1998).","journal-title":"Curr. Opin. Immunol."},{"key":"58460_CR30","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1038\/362245a0","volume":"362","author":"M Kopf","year":"1993","unstructured":"Kopf, M. et al. Disruption of the murine IL-4 gene blocks Th2 cytokine responses. Nature 362, 245\u2013248 (1993).","journal-title":"Nature"},{"key":"58460_CR31","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1016\/j.cell.2012.07.021","volume":"150","author":"W Kastenmuller","year":"2012","unstructured":"Kastenmuller, W., Torabi-Parizi, P., Subramanian, N., Lammermann, T. & Germain, R. N. A spatially-organized multicellular innate immune response in lymph nodes limits systemic pathogen spread. Cell 150, 1235\u20131248 (2012).","journal-title":"Cell"},{"key":"58460_CR32","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-017-0027-3","volume":"2","author":"M Coccia","year":"2017","unstructured":"Coccia, M. et al. Cellular and molecular synergy in AS01-adjuvanted vaccines results in an early IFNgamma response promoting vaccine immunogenicity. NPJ Vaccines 2, 25 (2017).","journal-title":"NPJ Vaccines"},{"key":"58460_CR33","unstructured":"Murphy, K. M., Weaver, C., Berg, L. J. Janeway\u2019s Immunobiology 10th edn (W. W. Norton & Company, 2022)."},{"key":"58460_CR34","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1038\/s41590-023-01510-4","volume":"24","author":"M K\u00fcnzli","year":"2023","unstructured":"K\u00fcnzli, M. & Masopust, D. CD4\u2009+\u2009T cell memory. Nat. Immunol. 24, 903\u2013914 (2023).","journal-title":"Nat. Immunol."},{"key":"58460_CR35","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1038\/nm.2142","volume":"16","author":"TM Strutt","year":"2010","unstructured":"Strutt, T. M. et al. Memory CD4\u2009+\u2009T cells induce innate responses independently of pathogen. Nat. Med. 16, 558\u2013564 (2010).","journal-title":"Nat. Med."},{"key":"58460_CR36","doi-asserted-by":"publisher","first-page":"4904","DOI":"10.1128\/iai.65.12.4904-4908.1997","volume":"65","author":"J Barbic","year":"1997","unstructured":"Barbic, J., Leef, M. F., Burns, D. L. & Shahin, R. D. Role of gamma interferon in natural clearance of Bordetella pertussis infection. Infect. Immun. 65, 4904\u20134908 (1997).","journal-title":"Infect. Immun."},{"key":"58460_CR37","doi-asserted-by":"publisher","first-page":"2579","DOI":"10.1002\/eji.200425092","volume":"34","author":"P Byrne","year":"2004","unstructured":"Byrne, P., Mcguirk, P., Todryk, S. & Mills, K. H. G. Depletion of NK cells results in disseminating lethal infection with Bordetella pertussis associated with a reduction of antigen\u2010specific Th1 and enhancement of Th2, but not Tr1 cells. Eur. J. Immunol. 34, 2579\u20132588 (2004).","journal-title":"Eur. J. Immunol."},{"key":"58460_CR38","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-46560-w","volume":"15","author":"J Gillard","year":"2024","unstructured":"Gillard, J. et al. Antiviral responses induced by Tdap-IPV vaccination are associated with persistent humoral immunity to Bordetella pertussis. Nat. Commun. 15, 2133 (2024).","journal-title":"Nat. Commun."},{"key":"58460_CR39","doi-asserted-by":"publisher","first-page":"155313","DOI":"10.1016\/j.cyto.2020.155313","volume":"137","author":"R da Silva Antunes","year":"2021","unstructured":"da Silva Antunes, R. et al. Lack of evidence supporting a role of IFN-beta and TGF-beta in differential polarization of Bordetella pertussis specific-T cell responses. Cytokine 137, 155313 (2021).","journal-title":"Cytokine"},{"key":"58460_CR40","doi-asserted-by":"publisher","first-page":"e141023","DOI":"10.1172\/jci.insight.141023","volume":"6","author":"R da Silva Antunes","year":"2021","unstructured":"da Silva Antunes, R. et al. A system-view of Bordetella pertussis booster vaccine responses in adults primed with whole-cell versus acellular vaccine in infancy. JCI Insight 6, e141023 (2021).","journal-title":"JCI Insight"},{"key":"58460_CR41","doi-asserted-by":"publisher","first-page":"983","DOI":"10.4049\/jimmunol.1600318","volume":"197","author":"JM Dan","year":"2016","unstructured":"Dan, J. M. et al. A cytokine-independent approach to identify antigen-specific human germinal center T follicular helper cells and rare antigen-specific CD4\u2009+\u2009T cells in blood. J. Immunol. 197, 983\u2013993 (2016).","journal-title":"J. Immunol."},{"key":"58460_CR42","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1038\/nri1604","volume":"5","author":"LC Platanias","year":"2005","unstructured":"Platanias, L. C. Mechanisms of type-I- and type-II-interferon-mediated signalling. Nat. Rev. Immunol. 5, 375\u2013386 (2005).","journal-title":"Nat. Rev. Immunol."},{"key":"58460_CR43","doi-asserted-by":"publisher","first-page":"1970","DOI":"10.3389\/fimmu.2017.01970","volume":"8","author":"M Metzemaekers","year":"2017","unstructured":"Metzemaekers, M., Vanheule, V., Janssens, R., Struyf, S. & Proost, P. Overview of the mechanisms that may contribute to the non-redundant activities of interferon-inducible CXC chemokine receptor 3 ligands. Front. Immunol. 8, 1970 (2017).","journal-title":"Front. Immunol."},{"key":"58460_CR44","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1084\/jem.183.3.901","volume":"183","author":"E Murphy","year":"1996","unstructured":"Murphy, E. et al. Reversibility of T helper 1 and 2 populations is lost after long-term stimulation. J. Exp. Med. 183, 901\u2013913 (1996).","journal-title":"J. Exp. Med."},{"key":"58460_CR45","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1038\/cr.2009.138","volume":"20","author":"J Zhu","year":"2010","unstructured":"Zhu, J. & Paul, W. E. Heterogeneity and plasticity of T helper cells. Cell Res. 20, 4\u201312 (2010).","journal-title":"Cell Res."},{"key":"58460_CR46","doi-asserted-by":"publisher","first-page":"1043109","DOI":"10.3389\/fimmu.2023.1043109","volume":"14","author":"SK Verma","year":"2023","unstructured":"Verma, S. K. et al. New-age vaccine adjuvants, their development, and future perspective. Front. Immunol. 14, 1043109 (2023).","journal-title":"Front. Immunol."},{"key":"58460_CR47","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1038\/s41392-023-01557-7","volume":"8","author":"T Zhao","year":"2023","unstructured":"Zhao, T. et al. Vaccine adjuvants: mechanisms and platforms. Signal Transduct. Target. Ther. 8, 283 (2023).","journal-title":"Signal Transduct. Target. Ther."},{"key":"58460_CR48","unstructured":"(WHO) WHO. Prequalified vaccines (DTP acellular and whole-cell). https:\/\/extranet.who.int\/prequal\/vaccines\/prequalified-vaccines (2023)."},{"key":"58460_CR49","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.jconrel.2013.11.013","volume":"174","author":"HP Patil","year":"2014","unstructured":"Patil, H. P. et al. Evaluation of monophosphoryl lipid A as adjuvant for pulmonary delivered influenza vaccine. J. Control Release 174, 51\u201362 (2014).","journal-title":"J. Control Release"},{"key":"58460_CR50","doi-asserted-by":"publisher","first-page":"649","DOI":"10.3390\/vaccines11030649","volume":"11","author":"Y Li","year":"2023","unstructured":"Li, Y. & Chen, X. CpG 1018 is an effective adjuvant for influenza nucleoprotein. Vaccines 11, 649 (2023).","journal-title":"Vaccines"},{"key":"58460_CR51","doi-asserted-by":"publisher","first-page":"325","DOI":"10.4161\/hv.22755","volume":"9","author":"C Asokanathan","year":"2013","unstructured":"Asokanathan, C., Corbel, M. & Xing, D. A CpG-containing oligodeoxynucleotide adjuvant for acellular pertussis vaccine improves the protective response against Bordetella pertussis. Hum. Vaccin Immunother. 9, 325\u2013331 (2013).","journal-title":"Hum. Vaccin Immunother."},{"key":"58460_CR52","doi-asserted-by":"publisher","first-page":"5229","DOI":"10.1016\/j.vaccine.2022.07.030","volume":"40","author":"MA DeJong","year":"2022","unstructured":"DeJong, M. A. et al. CpG 1018(R) adjuvant enhances Tdap immune responses against Bordetella pertussis in mice. Vaccine 40, 5229\u20135240 (2022).","journal-title":"Vaccine"},{"key":"58460_CR53","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1093\/cid\/ciz840","volume":"71","author":"H de Graaf","year":"2020","unstructured":"de Graaf, H. et al. Controlled human infection with Bordetella pertussis induces asymptomatic, immunizing colonization. Clin. Infect. Dis. 71, 403\u2013411 (2020).","journal-title":"Clin. Infect. Dis."},{"key":"58460_CR54","unstructured":"(CCfV) CCfV. Establishing a controlled human infection model of Bordetella pertussis https:\/\/www.challengeunit.ca\/pertussis-chim (2022)."},{"key":"58460_CR55","doi-asserted-by":"publisher","first-page":"e018594","DOI":"10.1136\/bmjopen-2017-018594","volume":"7","author":"H de Graaf","year":"2017","unstructured":"de Graaf, H. et al. Investigating Bordetella pertussis colonisation and immunity: protocol for an inpatient controlled human infection model. BMJ Open 7, e018594 (2017).","journal-title":"BMJ Open"},{"key":"58460_CR56","doi-asserted-by":"publisher","first-page":"e0169086","DOI":"10.1371\/journal.pone.0169086","volume":"12","author":"R da Silva Antunes","year":"2017","unstructured":"da Silva Antunes, R. et al. Definition of human epitopes recognized in tetanus toxoid and development of an assay strategy to detect ex vivo tetanus CD4\u2009+\u2009T cell responses. PLoS ONE 12, e0169086 (2017).","journal-title":"PLoS ONE"},{"key":"58460_CR57","doi-asserted-by":"publisher","first-page":"e95192","DOI":"10.1371\/journal.pone.0095192","volume":"9","author":"E Assarsson","year":"2014","unstructured":"Assarsson, E. et al. Homogenous 96-plex PEA immunoassay exhibiting high sensitivity, specificity, and excellent scalability. PLoS ONE 9, e95192 (2014).","journal-title":"PLoS ONE"},{"key":"58460_CR58","doi-asserted-by":"publisher","unstructured":"Niu Du. vijaybioinfo\/LJI_RNA_SEQ_PIPELINE_V2: bulk RNA-seq pipeline. https:\/\/doi.org\/10.5281\/zenodo.15008967 (2025).","DOI":"10.5281\/zenodo.15008967"},{"key":"58460_CR59","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love, M. I., Huber, W. & Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 550 (2014).","journal-title":"Genome Biol."},{"key":"58460_CR60","doi-asserted-by":"publisher","first-page":"2306","DOI":"10.21105\/joss.02306","volume":"5","author":"D Makowski","year":"2020","unstructured":"Makowski, D., Ben-Shachar, M., Patil, I. & L\u00fcdecke, D. Methods and algorithms for correlation analysis in R. J. Open Source Softw. 5, 2306 (2020).","journal-title":"J. Open Source Softw."},{"key":"58460_CR61","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-09234-6","volume":"10","author":"Y Zhou","year":"2019","unstructured":"Zhou, Y. et al. Metascape provides a biologist-oriented resource for the analysis of systems-level datasets. Nat. Commun. 10, 1523 (2019).","journal-title":"Nat. Commun."},{"key":"58460_CR62","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1016\/j.molcel.2010.05.004","volume":"38","author":"S Heinz","year":"2010","unstructured":"Heinz, S. et al. Simple combinations of lineage-determining transcription factors prime cis-regulatory elements required for macrophage and B cell identities. Mol. Cell 38, 576\u2013589 (2010).","journal-title":"Mol. Cell"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-58460-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-58460-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-58460-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,4]],"date-time":"2025-04-04T20:02:47Z","timestamp":1743796967000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-58460-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,1]]},"references-count":62,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["58460"],"URL":"https:\/\/doi.org\/10.1038\/s41467-025-58460-8","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,1]]},"assertion":[{"value":"17 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"3132"}}